TR3

Price range: $ 83 through $ 230

Dual GIP/GLP-1 receptor agonist. FDA-approved in some forms for type 2 diabetes. Not for Human Consumption. Research powder only.

Category:

Description

TR3 is a single-component peptide research compound designed for investigation of dual-pathway incretin signaling mechanisms. TR3 is a synthetic peptide analog engineered to interact with both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, providing a focused research platform for studying coordinated incretin receptor activity.

TR3 enables researchers to examine how dual receptor engagement influences intracellular signaling pathways, receptor synergy, and hormonal communication within controlled laboratory environments.

TR3 

TR3 represents a chemically modified synthetic peptide developed to exhibit high affinity for both GLP-1 and GIP receptors. Structural adaptations within the peptide backbone are designed to enhance molecular stability and support sustained receptor interaction under experimental conditions.

The dual-receptor design of TR3 distinguishes it from single-receptor incretin analogs, allowing for comparative analysis of mono-agonist versus dual-agonist signaling models in metabolic research systems.

Mechanistic Overview

The molecular mechanisms associated with TR3 involve simultaneous activation of GLP-1 and GIP receptor signaling pathways. These incretin pathways are involved in metabolic regulation, nutrient sensing, and endocrine communication at the cellular level. TR3 supports research into receptor cooperation, pathway integration, and downstream signal amplification.

This dual-pathway signaling profile allows researchers to investigate how combined incretin receptor engagement alters signaling dynamics compared to isolated receptor activation.

Research Applications

TR3 may be utilized in laboratory research focused on:

  • Dual incretin receptor signaling studies
  • GLP-1 and GIP pathway interaction research
  • Receptor synergism and signal integration analysis
  • Comparative incretin agonist research models

TR3 provides researchers with a streamlined compound for examining coordinated incretin signaling in controlled experimental settings.

Product Specifications

  • Product Name: TR3
  • Compound Type: Synthetic Peptide Research Compound
  • Primary Receptor Targets: GLP-1, GIP
  • Classification: Dual-Incretin Peptide Research Analog
  • Research Applications: Incretin signaling and receptor interaction studies
  • Storage: Refrigerated storage required (2–8°C)
  • Handling: Sterile laboratory handling required
  • Research Use Only: Not for human or animal consumption

Research Compliance Statement

This product is intended for research use only and is not approved for human or animal consumption, therapeutic use, or clinical application. TR3 is not intended for use in food, drugs, medical devices, or cosmetics. All research must be conducted in accordance with applicable institutional guidelines, laboratory safety standards, and regulatory requirements.

Why Choose Firm Foundation Peptides?

Firm Foundation Peptides is the best place to buy peptides online. If you’re looking to buy research chemicals online, our one-stop-shop offers a wide range of third-party tested, high-quality research peptides — including top-tier peptides, nootropics, amino acids, research oils, liquid research compounds, and more!

Our products are routinely and rigorously tested for purity, with COAs verifiable through third-party laboratory testing services.

We also maintain reliable customer service to facilitate a smooth consumer experience, from pre-sale inquiries to after-sales concerns. Please contact us for questions about our products.

Additional information

Size

5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg

Reviews

There are no reviews yet.

Be the first to review “TR3”

Your email address will not be published. Required fields are marked *

You must be 21+ years or older to access this website.

By clicking “I Agree”, you confirm that you are of legal age and agree to our Terms & Conditions.